A major driver is receptor tyrosine kinase (RTK) signaling, particularly via the epidermal growth factor receptor (EGFR), which is overexpressed in 80–90% of HNSCC cases and signals downstream through PI3K, AKT, and mTOR to fuel tumor growth [55,56,57,58]. Here, PIK3CA is linked to neoplasm.